Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...

KENVUE Hedge Fund Activity. We have seen 533 institutional investors add shares of KENVUE stock to their portfolio, and 492 decrease their positions in their most recent quarter.

Kenvue (KVUE), the company behind Tylenol and Neutrogena, announced that Thibaut Mongon had left the company, naming Kirk ...

View the latest Kenvue Inc. (1KVUE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Kenvue stock trades for about 18 times the per-share earnings expected for 2026, compared with the multiple of 21 for its consumer healthcare peers. At a price/earnings ratio of 21, ...

Present Market Standing of Kenvue Trading volume stands at 5,028,386, with KVUE's price down by -1.6%, positioned at $23.11. RSI indicators show the stock to be may be approaching overbought ...

Shares of Kenvue Inc. KVUE advanced 1.53% to $23.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.63% to 5,604.14 ...

In a report released today, Anna Lizzul from Bank of America Securities reiterated a Buy rating on Kenvue, Inc. (KVUE – Research Report), with a price target of $25.00. The company’s shares ...

Shares of Kenvue Inc. KVUE shed 2.08% to $23.50 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the Dow Jones Industrial Average DJIA remaining ...

In my view, Kenvue presented acceptably solid results for 2024. Check out my options-based strategy for KVUE stock that includes short calls and short puts.

Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs. Organic sales are still expected to rise 2% to 4% this year, the company ...

In the first half of fiscal 2025, the company generated a staggering $9.42 billion in free cash flow, which supported stock repurchases of $8.41 billion and $2.33 billion in dividends.